Cytokinetics Stock Forward View - Total Risk Alpha

CYTK Stock  USD 62.92  0.58  0.93%   
Cytokinetics Stock outlook is based on your current time horizon. Although Cytokinetics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Cytokinetics' systematic risk associated with finding meaningful patterns of Cytokinetics fundamentals over time.
As of now the rsi of Cytokinetics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Cytokinetics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Cytokinetics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cytokinetics' stock price prediction:
EPS Estimate Next Quarter
(1.57)
EPS Estimate Current Year
(6.11)
EPS Estimate Next Year
(6.07)
Wall Street Target Price
89.9444
EPS Estimate Current Quarter
(1.63)
Using Cytokinetics hype-based prediction, you can estimate the value of Cytokinetics from the perspective of Cytokinetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Cytokinetics using Cytokinetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Cytokinetics using crowd psychology based on the activity and movement of Cytokinetics' stock price.

Cytokinetics Short Interest

An investor who is long Cytokinetics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Cytokinetics and may potentially protect profits, hedge Cytokinetics with its derivative instruments, or be ready for some potential downside.
200 Day MA
48.9568
Short Percent
0.1419
Short Ratio
6.08
Shares Short Prior Month
13.8 M
50 Day MA
63.638

Cytokinetics Relative Strength Index

Cytokinetics Hype to Price Pattern

Investor biases related to Cytokinetics' public news can be used to forecast risks associated with an investment in Cytokinetics. The trend in average sentiment can be used to explain how an investor holding Cytokinetics can time the market purely based on public headlines and social activities around Cytokinetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Cytokinetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Cytokinetics.

Cytokinetics Implied Volatility

    
  1.16  
Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.

Cytokinetics after-hype prediction price

    
  USD 62.49  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Cytokinetics to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.

Prediction based on Rule 16 of the current Cytokinetics contract

Based on the Rule 16, the options market is currently suggesting that Cytokinetics will have an average daily up or down price movement of about 0.0725% per day over the life of the 2026-05-15 option contract. With Cytokinetics trading at USD 62.92, that is roughly USD 0.0456 . If you think that the market is fully incorporating Cytokinetics' daily price movement you should consider acquiring Cytokinetics options at the current volatility level of 1.16%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-05-15 Cytokinetics Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Cytokinetics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cytokinetics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cytokinetics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cytokinetics' open interest, investors have to compare it to Cytokinetics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cytokinetics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cytokinetics. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Cytokinetics Additional Predictive Modules

Most predictive techniques to examine Cytokinetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cytokinetics using various technical indicators. When you analyze Cytokinetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cytokinetics has current Total Risk Alpha of 0.
Check Cytokinetics VolatilityBacktest CytokineticsInformation Ratio  

Cytokinetics Trading Date Momentum

On February 09 2026 Cytokinetics was traded for  62.92  at the closing time. The top price for the day was 62.92  and the lowest listed price was  61.00 . There was no trading activity during the period 0.0. Lack of trading volume on February 9, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.92% .
Compare Cytokinetics to competition

Other Forecasting Options for Cytokinetics

For every potential investor in Cytokinetics, whether a beginner or expert, Cytokinetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cytokinetics Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cytokinetics. Basic forecasting techniques help filter out the noise by identifying Cytokinetics' price trends.

Cytokinetics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytokinetics stock to make a market-neutral strategy. Peer analysis of Cytokinetics could also be used in its relative valuation, which is a method of valuing Cytokinetics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Cytokinetics Market Strength Events

Market strength indicators help investors to evaluate how Cytokinetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cytokinetics shares will generate the highest return on investment. By undertsting and applying Cytokinetics stock market strength indicators, traders can identify Cytokinetics entry and exit signals to maximize returns.

Cytokinetics Risk Indicators

The analysis of Cytokinetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cytokinetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cytokinetics stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Cytokinetics

The number of cover stories for Cytokinetics depends on current market conditions and Cytokinetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cytokinetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cytokinetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cytokinetics Short Properties

Cytokinetics' future price predictability will typically decrease when Cytokinetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cytokinetics often depends not only on the future outlook of the potential Cytokinetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cytokinetics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding112 M
Cash And Short Term Investments1.1 B
When determining whether Cytokinetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cytokinetics Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cytokinetics Stock. Highlighted below are key reports to facilitate an investment decision about Cytokinetics Stock:
Check out Historical Fundamental Analysis of Cytokinetics to cross-verify your projections.
For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. Projected growth potential of Cytokinetics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cytokinetics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(6.30)
Revenue Per Share
0.733
Quarterly Revenue Growth
3.181
Return On Assets
(0.25)
Return On Equity
(5.72)
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cytokinetics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cytokinetics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cytokinetics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.